Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Vigilare Biotech ApS
APS
Dissolved
Advertising protection
CVR 41472308
Lergyden 48, 5492
Vissenbjerg
Forskning og eksperimentel udvikling indenfor bioteknologi
·
NACE 721100
Est. 2020 · 6 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Forskning og eksperimentel udvikling indenfor bioteknologi
/
Vigilare Biotech ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2021
EBITDA
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2021
Income statement
DKK thousands
Item
2021
Gross profit
325
Staff expenses
-0
EBITDA
325
Depreciation & amort.
-5
EBIT
320
Net financials
-2
Profit before tax
319
Tax
70
Net profit
249
Balance sheet
DKK thousands
Item
2021
Total assets
360
Equity
289
Long-term debt
0
Short-term debt
71
Total debt
71
Financial ratios
5-year trend
EBITDA margin (of gross profit)
100.0%
This company
2021
2021
Equity ratio
80.3%
This company
38.2%
Market median
+110% vs market
2021
2021
Return on equity
86.2%
This company
18.4%
Market median
+368% vs market
2021
2021
Net profit margin (of gross profit)
76.7%
This company
2021
2021
Asset turnover (of gross profit)
0.90×
This company
2021
2021
Debt / equity
0.25×
This company
0.62×
Market median
+60% vs market
2021
2021
Annual reports & filings
Annual report 2021
Filed via CVR / Virk · Period 2020-06-17 – 2021-05-31
View
PDF
More on Vigilare Biotech ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
